Direxion Daily LLY Bull 2X ETF (ELIL)
NASDAQ: ELIL · Real-Time Price · USD
17.27
+0.21 (1.25%)
At close: Apr 28, 2026, 4:00 PM EDT
17.17
-0.10 (-0.58%)
After-hours: Apr 28, 2026, 5:31 PM EDT
1.25% (1D)
| Assets | $11.92M |
| Expense Ratio | 1.07% |
| PE Ratio | n/a |
| Shares Out | 675,001 |
| Dividend (ttm) | $3.14 |
| Dividend Yield | 18.18% |
| Ex-Dividend Date | Mar 24, 2026 |
| Payout Ratio | n/a |
| 1-Year Return | -33.12% |
| Volume | 98,640 |
| Open | 17.30 |
| Previous Close | 17.06 |
| Day's Range | 16.87 - 17.40 |
| 52-Week Low | 11.50 |
| 52-Week High | 34.28 |
| Beta | n/a |
| Holdings | 10 |
| Inception Date | Mar 26, 2025 |
About ELIL
Fund Home PageThe Direxion Daily LLY Bull 2X ETF (ELIL) is an exchange-traded fund that mostly invests in health care equity. The fund provides 2x leveraged exposure, less fees and expenses, to the daily price movement for shares of Eli Lilly and Company stock. ELIL was launched on Mar 26, 2025 and is issued by Direxion.
Asset Class Equity
Category Trading--Leveraged Equity
Stock Exchange NASDAQ
Ticker Symbol ELIL
ETF Provider Direxion
Top 10 Holdings
100.00% of assets| Name | Symbol | Weight |
|---|---|---|
| Goldman Sachs Fin Gov 465 Institut | n/a | 32.05% |
| Dreyfus Trsry Securities Cash Mgmt | n/a | 28.36% |
| Dreyfus Govt Cash Man Ins | n/a | 18.00% |
| Goldman Finl Sq Trsry Inst 506 | n/a | 17.19% |
| Eli Lilly and Company | LLY | 15.08% |
| Cash | n/a | 0.02% |
| Eli Lilly And Co Swap | n/a | -1.18% |
| Eli Lilly And Co Swap | n/a | -2.38% |
| Eli Lilly And Co Swap | n/a | -3.25% |
| Eli Lilly And Co Swap | n/a | -3.88% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 24, 2026 | $0.05318 | Mar 31, 2026 |
| Dec 23, 2025 | $0.13209 | Dec 31, 2025 |
| Dec 10, 2025 | $2.75962 | Dec 17, 2025 |
| Sep 23, 2025 | $0.09221 | Sep 30, 2025 |
| Jun 24, 2025 | $0.10303 | Jul 1, 2025 |
News
Healthcare Opportunities And Risks Collide For Direxion's Eli Lilly-Focused ELIL, ELIS ETFs
As the largest publicly traded U.S. healthcare enterprise, Eli Lilly & Co. (NYSE:LLY) has historically offered investors a reliable avenue for growth. Indeed, this narrative has been particularly powe...
7 months ago - Benzinga